Major gene partners of a favorable biomarker in ER(+) breast cancer

ChEBI2010-11-04 更新2026-07-21 收录

乳腺癌基因组学

生物标志物互作网络

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-24124 数据链接链接失效反馈

官方服务：

资源简介：

Major gene partners of a favorable biomarker in ER(+) breast cancer

创建时间：

2010-11-04

Table_1_Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer.pdf

乳腺癌基因组学

肿瘤突变负荷

ObjectivesVarious genomic alterations and genomic signatures, including ERBB2 amplification, mutations in PIK3CA, AKT1, and ESR1, and tumor mutational burden (TMB), have become important biomarkers fo

NIAID Data Ecosystem120

Supplementary File 2 from Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer

乳腺癌基因组学

基因扩增突变协同

Supplementary File 2 from Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer

NIAID Data Ecosystem80

EGAS00001000292-sc-20121206 - samples

浸润性小叶癌

乳腺癌基因组学

Invasive lobular carcinoma (ILC) is the second most common histological subtype of breast cancer accounting for 10-15% of cases. ILC differs from invasive ductal carcinoma (IDC)with respect to epidemi

NIAID Data Ecosystem60

Additional file 5: of Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers

乳腺癌基因组学

癌症预后生物标志物

Table S4. List of genes differently expressed between normal and tumor METABRIC samples and with concordant results with TCGA breast cancer analyses. (XLSX 39 kb)

Figshare2019-03-14 更新80

Additional file 4 of Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models

乳腺癌基因组学

拷贝数变异分析

Additional file 4: Table S7. Comparison of the genes with copy number alterations in COSMIC, Ben-David et al and this study.

NIAID Data Ecosystem70